379 related articles for article (PubMed ID: 12066224)
1. HPV detection in cervical cancer patients in northern Poland.
Dybikowska A; Licznerski P; Podhajska A
Oncol Rep; 2002; 9(4):871-4. PubMed ID: 12066224
[TBL] [Abstract][Full Text] [Related]
2. Detection of human papillomavirus in urine and cervical swabs from patients with invasive cervical cancer.
Stanczuk GA; Kay P; Allan B; Chirara M; Tswana SA; Bergstrom S; Sibanda EN; Williamson AL
J Med Virol; 2003 Sep; 71(1):110-4. PubMed ID: 12858416
[TBL] [Abstract][Full Text] [Related]
3. [Estimation of HPV infection presence in cytological smears in a group of asymptomatic women].
Łukaszuk K; Liss J; Zalewski J; Roter M; Brzóska B; Debniak J
Wiad Lek; 2001; 54(9-10):508-15. PubMed ID: 11816294
[TBL] [Abstract][Full Text] [Related]
4. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of human papillomavirus-consensus primers for HPV detection by the polymerase chain reaction.
Harnish DG; Belland LM; Scheid EE; Rohan TE
Mol Cell Probes; 1999 Feb; 13(1):9-21. PubMed ID: 10024428
[TBL] [Abstract][Full Text] [Related]
6. [Human Papilloma virus in Quechua women from Jujuy with high frequency of cervical cancer: viral types and HPV-16 variants].
Picconi MA; Gronda J; Alonio LV; Villa LL; Sichero L; Miranda S; Barcena M; Teyssie A
Medicina (B Aires); 2002; 62(3):209-20. PubMed ID: 12150002
[TBL] [Abstract][Full Text] [Related]
7. Detection of high-risk HPV types by the hybrid capture 2 test.
Terry G; Ho L; Londesborough P; Cuzick J; Mielzynska-Lohnas I; Lorincz A
J Med Virol; 2001 Sep; 65(1):155-62. PubMed ID: 11505458
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens.
Gupta A; Arora R; Gupta S; Prusty BK; Kailash U; Batra S; Das BC
J Clin Virol; 2006 Nov; 37(3):190-4. PubMed ID: 16931139
[TBL] [Abstract][Full Text] [Related]
9. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types.
Castle PE; Schiffman M; Burk RD; Wacholder S; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Lorincz A
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1394-9. PubMed ID: 12433717
[TBL] [Abstract][Full Text] [Related]
10. Comparisons of HPV DNA detection by MY09/11 PCR methods.
Castle PE; Schiffman M; Gravitt PE; Kendall H; Fishman S; Dong H; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Lorincz A; Schussler JE; Burk RD
J Med Virol; 2002 Nov; 68(3):417-23. PubMed ID: 12226831
[TBL] [Abstract][Full Text] [Related]
11. Analytic sensitivities of hybrid-capture, consensus and type-specific polymerase chain reactions for the detection of human papillomavirus type 16 DNA.
Cavuslu S; Mant C; Starkey WG; Bible JM; Biswas C; Kell B; Rice P; Best JM; Cason J
J Med Virol; 1996 Aug; 49(4):319-24. PubMed ID: 8877765
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of oncogenic human papillomavirus in the genital tract of women with human immunodeficiency virus.
Volkow P; Rubí S; Lizano M; Carrillo A; Vilar-Compte D; García-Carrancá A; Sotelo R; García B; Sierra-Madero J; Mohar A
Gynecol Oncol; 2001 Jul; 82(1):27-31. PubMed ID: 11426958
[TBL] [Abstract][Full Text] [Related]
13. Clinical and epidemiological correlations between the infection with HPV 16 and HPV 18 and female cervical lesions.
Stoian M; Repanovici R; Corniţescu F
Rom J Virol; 1995; 46(3-4):161-70. PubMed ID: 9179967
[TBL] [Abstract][Full Text] [Related]
14. [Molecular variants of human papillomaviruses types 16, 18, and 45 in tumors of the uterine cervix in Mexico].
Lizano M; García-Carrancá A
Gac Med Mex; 1997; 133 Suppl 1():43-8. PubMed ID: 9504102
[TBL] [Abstract][Full Text] [Related]
15. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India.
Munirajan AK; Kannan K; Bhuvarahamurthy V; Ishida I; Fujinaga K; Tsuchida N; Shanmugam G
Gynecol Oncol; 1998 Jun; 69(3):205-9. PubMed ID: 9648588
[TBL] [Abstract][Full Text] [Related]
16. Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma.
Dong SM; Pai SI; Rha SH; Hildesheim A; Kurman RJ; Schwartz PE; Mortel R; McGowan L; Greenberg MD; Barnes WA; Sidransky D
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):3-6. PubMed ID: 11815394
[TBL] [Abstract][Full Text] [Related]
17. Detection and typing of human papillomaviruses by means of polymerase chain reaction and fragment length polymorphism in male genital lesions.
Grce M; Husnjak K; Skerlev M; Lipozencić J; Pavelić K
Anticancer Res; 2000; 20(3B):2097-102. PubMed ID: 10928159
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus and human cytomegalovirus DNAs presence in patients suspected of condylomatosis or papillomatosis.
Anton G; Achim R; Pleşa A; Repanovici R
Rom J Virol; 1998; 49(1-4):83-8. PubMed ID: 10892429
[TBL] [Abstract][Full Text] [Related]
19. Low incidence of HPV DNA in sera of pretreatment cervical cancer patients.
Liu VW; Tsang P; Yip A; Ng TY; Wong LC; Ngan HY
Gynecol Oncol; 2001 Aug; 82(2):269-72. PubMed ID: 11531278
[TBL] [Abstract][Full Text] [Related]
20. A cumulative case-control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections.
Rousseau MC; Franco EL; Villa LL; Sobrinho JP; Termini L; Prado JM; Rohan TE
Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):469-76. PubMed ID: 10815691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
